Top Markets
#1 MowCat MowCat +48.94%
#2 Velvet Velvet +24.42%
#3 Bermuda Shorts Bermuda Shorts +24.20%
#4 Quack AI Quack AI +22.94%
#5 Derive Derive +20.22%
#6 Audiera Audiera +19.04%
#7 Biconomy Biconomy +18.54%
#8 Geodnet Geodnet +14.53%
#9 aPriori aPriori +14.25%
#10 SkyAI SkyAI +13.63%
Coin of the day
MowCat MowCat
Inställningar
Språk
SVENSKA
Valuta
USD
Tema
IMV Inc. IMV Inc.

IMV Inc.

IMV
Rankning i aktier #35289
IMV Inc. is a clinical-stage biotechnology company dedicated to the development... IMV Inc. is a clinical-stage biotechnology company dedicated to the development of innovative immunotherapies. The company utilizes its proprietary DPX immune-educating technology platform to create a portfolio of treatments for various solid and hematological cancers. Its leading investigational drug, maveropepimut-S, is a DPX-based immunotherapy designed to target cancer cells that express survivin. Maveropepimut-S is currently undergoing Phase II clinical trials for diffuse large B-cell lymphoma, ovarian cancer, and specific bladder, liver, and microsatellite instability-high tumors, with Phase I trials also active for breast cancer. Beyond its primary candidate, IMV is also advancing DPX-SurMAGE, which is in Phase I clinical trials for bladder cancer, and is developing DPX-COVID-19 and DPX-RSV to address infectious diseases. Originally founded in 2000 as Immunovaccine Inc., the company adopted the name IMV Inc. in May 2018 and operates from its headquarters in Dartmouth, Canada.
Aktiekurs
$0.82959892
Senast synkroniserad: 2023-05-23
Marknadsvärde
$4.16M
Förändring (1 dag)
-0.04%
Förändring (1 år)
0.00%
Land
CA
Handel IMV Inc. (IMV)

Kategori

Healthcare
Aktiekurshistorik för IMV Inc. (IMV)
Högsta slutkurs: $0.83 den 2023-05-01

Lägsta slutkurs: $10.12 den 2012-08-01
Aktiekurshistorik för IMV Inc. från 2012 till 2026
Årlig aktiekursutveckling
År Prestanda
2023 -68.78%
2022 -80.40%
2021 -58.02%
2020 14.41%
2019 -48.63%
2018 2.19%
2017 210.21%
2016 -3.76%
2015 -10.27%
2014 42.27%
2013 23.64%
2012 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE